We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Cylindromatosis (Turban Tumor Syndrome) (CYLD) Antibodies|
|Epitope||AA 618-956 Alternatives|
|Reactivity||Human, Rat (Rattus) Alternatives|
|Conjugate||This CYLD antibody is un-conjugated Alternatives|
Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-CYLD AntibodyTarget Details CYLD Application Details Handling Images
|Purpose||Rabbit IgG polyclonal antibody for Ubiquitin carboxyl-terminal hydrolase CYLD(CYLD) detection. Tested with WB in Human,Rat.|
|Cross-Reactivity (Details)||No cross reactivity with other proteins.|
Rabbit IgG polyclonal antibody for Ubiquitin carboxyl-terminal hydrolase CYLD(CYLD) detection. Tested with WB in Human,Rat.
Gene Name: cylindromatosis (turban tumor syndrome)
Protein Name: Ubiquitin carboxyl-terminal hydrolase CYLD
|Purification||Immunogen affinity purified.|
|Immunogen||E.coli-derived human CYLD recombinant protein (Position: D618-K956). Human CYLD shares 97.6% and 97.9% amino acid (aa) sequence identity with mouse and rat CYLD, respectively.|
Target Details CYLDProduct Details anti-CYLD Antibody Application Details Handling Images back to top
|Alternative Name||CYLD (CYLD Antibody Abstract)|
CYLD is localized on the long arm of chromosome 16. This gene encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Synonyms: BRSS antibody|CDMT antibody|Cyld antibody|CYLD gene antibody|CYLD_HUMAN antibody|CYLD1 antibody|CYLDI antibody|cylindromatosis (turban tumor syndrome) antibody|cylindromatosis 1 antibody|Deubiquitinating enzyme CYLD antibody|EAC antibody|HSPC057 antibody|KIAA0849 antibody|MFT antibody|MFT1 antibody|Probable ubiquitin carboxyl terminal hydrolase CYLD antibody|SBS antibody|TEM antibody|turban tumor syndrome antibody|Ubiquitin carboxyl-terminal hydrolase CYLD antibody|ubiquitin specific peptidase like 2 antibody|ubiquitin thioesterase CYLD antibody|Ubiquitin thiolesterase CYLD antibody|Ubiquitin-specific processing protease CYLD antibody|Ubiquitin-specific-processing protease CYLD antibody| USPL2 antibody
|Pathways||Apoptosis, Activation of Innate immune Response|
Application DetailsProduct Details anti-CYLD Antibody Target Details CYLD Handling Images back to top
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human, Rat
Notes: Tested Species: Species with positive results.
Other applications have not been tested. Optimal dilutions should be determined by end users.
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
|Restrictions||For Research Use only|
HandlingProduct Details anti-CYLD Antibody Target Details CYLD Application Details Images back to top
|Reconstitution||Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.|
|Buffer||Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.|
|Precaution of Use||This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
ImagesProduct Details anti-CYLD Antibody Target Details CYLD Application Details Handling back to top